Abstract
Background:
The objective of the study was to analyze the association of apelin gene (APLN) single nucleotide polymorphisms (SNPs) and type 2 diabetes mellitus (T2DM).
Methods:
A total of 1966 subjects were enrolled in this study, including 168 cases (first batch), 330 cases (second batch), and 1468 nondiabetic controls. The SNPs in the HapMap-HCB of APLN were detected using Sequenom MassARRAY SNP technology and included rs2281068, rs3115757, rs2235309, and rs2235310. The related clinical characteristics with glucose metabolism were tested, including the fasting blood glucose (FPG), insulin (INS), C-peptide, glycosylated hemoglobin (HbA1c), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C).
Results:
A correlation between rs3115757 and rs2281068 and diabetes was observed in first batch. Thus, we compared the SNPs (rs3115757 and rs2281068) between the cases and controls after more cases were enrolled. In addition, the results showed a significant correlation between APLN rs2281068 and diabetes (p<0.05). However, age, BMI, WC, blood pressure, and serum markers in T2DM had no relationship with APLN rs2281068.
Conclusions:
The SNP rs2281068 in APLN is significantly related to diabetes mellitus in a Chinese population.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This study was funded by a grant from the Shanghai Science and Technology Development (114119b0400 and 15411970700).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Xu Y, Wang L, He J, Bi Y, Li M, et al. Prevalence and control of diabetes in Chinese adults. J Am Med Assoc 2013;310:948–59.10.1001/jama.2013.168118Search in Google Scholar
2. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:3–19.10.1007/s00125-002-1009-0Search in Google Scholar
3. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444: 840–6.10.1038/nature05482Search in Google Scholar
4. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006;64:355–65.10.1111/j.1365-2265.2006.02474.xSearch in Google Scholar
5. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005;146:1764–71.10.1210/en.2004-1427Search in Google Scholar
6. Zhu S, Cheng G, Zhu H, Guan G. A study of genes involved in adipocyte differentiation. J Pediatr Endocrinol Metab 2015;28:93–9.10.1515/jpem-2014-0002Search in Google Scholar
7. Pereira SS, Alvarez-Leite JI. Low-grade inflammation, obesity, and diabetes. Curr Obes Rep 2014;3:422–31.10.1007/s13679-014-0124-9Search in Google Scholar
8. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000;74:34–41.10.1046/j.1471-4159.2000.0740034.xSearch in Google Scholar
9. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998;251:471–6.10.1006/bbrc.1998.9489Search in Google Scholar
10. O’Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993;136: 355–60.10.1016/0378-1119(93)90495-OSearch in Google Scholar
11. Kang Y, Kim J, Anderson JP, Wu J, Gleim SR, et al. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development. Circ Res 2013;113:22–31.10.1161/CIRCRESAHA.113.301324Search in Google Scholar PubMed PubMed Central
12. Reaux A, De Mota N, Skultetyova I, Lenkei Z, El Messari S, et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 2001;77:1085–96.10.1046/j.1471-4159.2001.00320.xSearch in Google Scholar PubMed
13. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003;108:1432–9.10.1161/01.CIR.0000091235.94914.75Search in Google Scholar PubMed
14. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005;65:73–82.10.1016/j.cardiores.2004.08.018Search in Google Scholar PubMed PubMed Central
15. Sato T, Suzuki T, Watanabe H, Kadowaki A, Fukamizu A, et al. Apelin is a positive regulator of ACE2 in failing hearts. J Clin Invest 2013;123:5203–11.10.1172/JCI69608Search in Google Scholar PubMed PubMed Central
16. Xu S, Tsao PS, Yue P. Apelin and insulin resistance: another arrow for the quiver? J Diabetes 2011;3:225–31.10.1111/j.1753-0407.2011.00132.xSearch in Google Scholar PubMed PubMed Central
17. Castan-Laurell I, Dray C, Knauf C, Kunduzova O, Valet P. Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol Metab 2012;23:234–41.10.1016/j.tem.2012.02.005Search in Google Scholar PubMed
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. PLINK: a tool set for whole genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559–75.10.1086/519795Search in Google Scholar PubMed PubMed Central
19. Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013;7:14–24.10.1007/s11684-013-0262-6Search in Google Scholar PubMed PubMed Central
20. Badawi A, Klip A, Haddad P, Cole DE, Bailo BG, et al. Type 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes 2010;3:173–86.10.2147/DMSO.S9089Search in Google Scholar
21. Ye J, McGuinness OP. Inflammation during obesity is not all bad: evidence from animal and human studies. Am J Physiol Endocrinol Metab 2013;304:E466–77.10.1152/ajpendo.00266.2012Search in Google Scholar PubMed PubMed Central
22. Drougard A, Duparc T, Brenachot X, Carneiro L, Gouazé A, et al. Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes. Antioxid Redox Signal 2014;20:557–73.10.1089/ars.2013.5182Search in Google Scholar PubMed PubMed Central
23. Heinonen MV, Purhonen AK, Miettinen P, Pääkkönen M, Pirinen E, et al. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept 2005;130:7–13.10.1016/j.regpep.2005.05.003Search in Google Scholar PubMed
24. Zhang Y, Shen C, Li X, Ren G, Fan X, et al. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes care 2009;32:e150.10.2337/dc09-1146Search in Google Scholar PubMed
25. Fan Y, Zhang Y, Li X, Zheng H, Song Y, et al. Treatment with metformin and a dipeptidyl peptidase-4 inhibitor elevates apelin levels in patients with type 2 diabetes mellitus. Drug Des Devel Ther 2015;9:4679–83.10.2147/DDDT.S85740Search in Google Scholar PubMed PubMed Central
26. Corvera S, Gealekman O. Adipose tissue angiogenesis: impact on obesity and type-2 diabetes. Biochim Biophys Acta 2014;1842:463–72.10.1016/j.bbadis.2013.06.003Search in Google Scholar PubMed PubMed Central
27. Yue P, Jin H, Xu S, Aillaud M, Deng AC, et al. Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms. Endocrinology 2011;152:59–68.10.1210/en.2010-0576Search in Google Scholar PubMed PubMed Central
28. Sawane M, Kajiya K, Kidoya H, Takagi M, Muramatsu F, et al. Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes 2013;62:1970–80.10.2337/db12-0604Search in Google Scholar PubMed PubMed Central
29. Zhang R, Hu C, Wang CR, Ma XJ, Bao YQ, et al. Association of apelin genetic variants with type 2 diabetes and related clinical features in Chinese Hans. Chin Med J 2009;122:1273–76.Search in Google Scholar
30. Liao YC, Chou WW, Li YN, Chuang SC, Lin WY, et al. Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women. Am J Clin Nutr 2011;94:921–8.10.3945/ajcn.110.008813Search in Google Scholar PubMed
31. Aboouf MA, Hamdy NM, Amin AI, El-Mesallamy HO. Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association withobesity and insulin resistance. Diabetes Res Clin Pract 2015;109:40–7.10.1016/j.diabres.2015.05.016Search in Google Scholar PubMed
32. Lu L, Katsaros D, Mayne ST, Risch HA, Benedetto C, et al. Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer. Carcinogenesis 2012;33:2119–25.10.1093/carcin/bgs243Search in Google Scholar PubMed
33. Lu L, Risch E, Deng Q, Biglia N, Picardo E, et al. An insulin-like growth factor-II intronic variant affects local DNA conformation and ovarian cancer survival. Carcinogenesis 2013;34:2024–30.10.1093/carcin/bgt168Search in Google Scholar PubMed
©2016 Walter de Gruyter GmbH, Berlin/Boston
